2022 annual financial data
ImmuCell 2022 Operating margin
ImmuCell 2022 operating margin with verified reported values.
Direct answer
Operating margin was -12.38%.
Operating income was -2,299,000 USD and net income was -2,494,000 USD.
Operating cash flow was -1,543,871 USD.
Get free ImmuCell email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 18,568,000 USD
- Operating income
- -2,299,000 USD
- Net income
- -2,494,000 USD
- Operating cash flow
- -1,543,871 USD